CymaBay Therapeutics, Inc. carries a market capitalization of 2.16B, placing it among publicly traded companies globally.
| Market Cap | 2.16B |
| Enterprise Value | N/A |
CymaBay Therapeutics, Inc.'s stock has gained approximately 218.15475% over the past 52 weeks. The 50-day moving average sits at 26.99, while the 200-day moving average is 17.16.
| Beta (5Y) | N/A |
| 52-Week Price Change | 218.15475% |
| 50-Day Moving Average | 26.99 |
| 200-Day Moving Average | 17.16 |
| Average Volume (20 Days) | N/A |